Leukemia & Lymphoma, Volume 61, Issue 12 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 61, Issue 12 (2020)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Volume 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
Allogeneic transplant for CML in chronic phase after failure of imatinib. Not needed or needlessly neglected?
Ok-kyong Chaekal & Koen van Besien
Pages: 2783-2784
Published online: 13 Sep 2020
CitationforAllogeneic transplant for CML in chronic phase after failure of imatinib. Not needed or needlessly neglected? | Full Text | References | PDF (246 KB) | EPUB
  • 198 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Primary refractory multiple myeloma – what role for high dose melphalan?
Sergio Giralt
Page: 2785
Published online: 14 Oct 2020
CitationforPrimary refractory multiple myeloma – what role for high dose melphalan? | Full Text | References | PDF (177.4 KB) | EPUB
  • 93 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Poor graft function, a significant and emerging clinical challenge post allogeneic stem cell transplantation
Ashvind A. Prabahran & David S. Ritchie
Pages: 2786-2787
Published online: 07 Aug 2020
CitationforPoor graft function, a significant and emerging clinical challenge post allogeneic stem cell transplantation | Full Text | References | PDF (357.9 KB) | EPUB
  • 160 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Eat and be healthy: nutritional status in myelodysplastic syndromes
Ashwin Kishtagari & Mikkael A. Sekeres
Pages: 2788-2789
Published online: 25 Jul 2020
CitationforEat and be healthy: nutritional status in myelodysplastic syndromes | Full Text | References | PDF (240.6 KB) | EPUB
  • 63 Views
  • 1 CrossRef citations
  • 0Altmetric

Review

Hematological manifestations of COVID-19
Alain Mina, Koen van Besien & Leonidas C. Platanias
Pages: 2790-2798
Published online: 09 Jul 2020
AbstractforHematological manifestations of COVID-19 | Full Text | References | PDF (681 KB) | EPUB
  • 7219 Views
  • 24 CrossRef citations
  • 0Altmetric

Original Articles

Article
CD74 is dispensable for development of chronic lymphocytic leukemia in Eµ-TCL1 transgenic mice
Romy Barthel, Oleg Fedorchenko, Tanja Velmans, Natascha Rosen, Phuong-Hien Nguyen, Nina Reinart, Alexandra Florin, Marco Herling, Michael Hallek & Günter Fingerle-Rowson
Pages: 2799-2810
Published online: 15 Jul 2020
AbstractforCD74 is dispensable for development of chronic lymphocytic leukemia in Eµ-TCL1 transgenic mice | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 256 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients
Bei Hu, Xiao Lin, Hans C. Lee, Xuelin Huang, Rebecca S. Slack Tidwell, Kwang Woo Ahn, Zhen-Huan Hu, Elias Jabbour, Srdan Verstovsek, Farhad Ravandi, Guillermo Garcia-Manero, Mohamed A. Kharfan-Dabaja, Nasheed M. Hossain, David I. Marks, Rammuriti T. Kamble, Yoshihiro Inamoto, Tamila Kindwall-Keller, Ayman Saad, Mark R. Litzow, Bipin N. Savani, Gregory A. Hale, Ulrike Bacher, Aaron T. Gerds, Jane L. Liesveld, Celalettin Ustun, Richard F. Olsson, Andrew Daly, Michael R. Grunwald, Melhem Solh, Zachariah DeFilipp, Mahmoud Aljurf, Baldeep Wirk, Gorgun Akpek, Taiga Nishihori, Jan Cerny, Sachiko Seo, Jack W. Hsu, Richard Champlin, Marcos de Lima, Edwin Alyea, Uday Popat, Ronald Sobecks, Bart L. Scott, Hagop Kantarjian, Jorge Cortes & Wael Saber
Pages: 2811-2820
Published online: 14 Jul 2020
AbstractforTiming of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 568 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group
Thoralf Lange, Christian Niederwieser, Arthur Gil, Rainer Krahl, Ulrich von Grünhagen, Haifa Kathrin Al-Ali, Kathleen Jentsch-Ullrich, Claudia Spohn, Volker Lakner, Michael Assmann, Christian Junghanss, Michael Cross, Rüdiger Hehlmann, Michael Deininger, Markus Pfirrmann & Dietger Niederwieser
Pages: 2821-2830
Published online: 16 Jul 2020
AbstractforNo advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 194 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia
Zhining Chen, Shimin Hu, Sa A. Wang, Marina Konopleva, Zhenya Tang, Jie Xu, Shaoying Li, Gokce Toruner, Beenu Thakral, L. Jeffrey Medeiros & Guilin Tang
Pages: 2831-2838
Published online: 23 Jul 2020
AbstractforChronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia | Full Text | References | PDF (917.9 KB) | EPUB
  • 841 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Conditioning regimen intensity and low-dose azacitidine maintenance after allogeneic hematopoietic cell transplantation for acute myeloid leukemia
Naveed Ali, Benjamin Tomlinson, Leland Metheny, Steven C. Goldstein, Pingfu Fu, Shufen Cao, Paolo Caimi, Rushang D. Patel, Juan Carlos Varela, Luisa Andrade, Jason W. Balls, Linda Baer, Megan Smith, Tori Smith, Megan Nelson, Marcos de Lima & Shahram Mori
Pages: 2839-2849
Published online: 10 Jul 2020
AbstractforConditioning regimen intensity and low-dose azacitidine maintenance after allogeneic hematopoietic cell transplantation for acute myeloid leukemia | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 590 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Long-term follow-up of acute lymphoblastic leukemia in young children treated by the SCMC-ALL-2009 protocol
Kangkang Liu, Jinhua Chu, Yu Dai, Aoshuang Jiang, Linhai Yang, Zhiwei Xie, Kunlong Zhang, Songji Tu, Huaju Cai, Zhengyu Wu & Ningling Wang
Pages: 2850-2858
Published online: 09 Jul 2020
AbstractforLong-term follow-up of acute lymphoblastic leukemia in young children treated by the SCMC-ALL-2009 protocol | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 177 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Comparing the outcomes between TMLI and non-TMLI conditioning regimens for adult high-risk acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a single-center experience
Xiaoyan Zhao, Xuan Lu, Liang Tang, Han Yan, Wenlan Chen, Wei Shi, Zhaodong Zhong, Yong You, Linghui Xia, Yu Hu & Huafang Wang
Pages: 2859-2867
Published online: 10 Jul 2020
AbstractforComparing the outcomes between TMLI and non-TMLI conditioning regimens for adult high-risk acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a single-center experience | Full Text | References | PDF (930.7 KB) | EPUB
  • 215 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Primary refractory multiple myeloma: a real-world experience with 85 cases
Artur Jurczyszyn, Anna Waszczuk-Gajda, Jorge J. Castillo, Katarzyna Krawczyk, Martin Stork, Ludek Pour, Lidia Usnarska-Zubkiewicz, Stanisław Potoczek, Iwona Hus, Julio Davila Valls, Parameswaran Hari, Saurabh Chhabra, Massimo Gentile, Gabor Mikala, Gergely Varga, Chor Sang Chim, Mark Fiala, Ravi Vij, Natalia Schutz, Marek Rodzaj, Agnieszka Porowska, David H. Vesole, Agnieszka Druzd-Sitek, Jan Walewski & Ajay K. Nooka
Pages: 2868-2875
Published online: 05 Jul 2020
AbstractforPrimary refractory multiple myeloma: a real-world experience with 85 cases | Full Text | References | PDF (1.2 MB) | EPUB
  • 462 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Severe infections following treatment for childhood cancer: a report from CYP-C
Marie-Claude Pelland-Marcotte, Jason D. Pole, Paul C. Nathan, Rinku Sutradhar & Lillian Sung
Pages: 2876-2884
Published online: 12 Jul 2020
AbstractforSevere infections following treatment for childhood cancer: a report from CYP-C | Full Text | References | PDF (942.7 KB) | EPUB | Supplemental
  • 317 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
EZH2-activating mutation: no reliable indicator for efficacy of methyltransferase inhibitors
Hilmar Quentmeier, Claudia Pommerenke, Vivien Hauer, Cord C. Uphoff, Margarete Zaborski & Hans G. Drexler
Pages: 2885-2893
Published online: 26 Jul 2020
AbstractforEZH2-activating mutation: no reliable indicator for efficacy of methyltransferase inhibitors | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 163 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Poor graft function after T cell-depleted allogeneic hematopoietic stem cell transplant
Ronit Reich-Slotky, Naima Al-Mulla, Rania Hafez, Javier Segovia-Gomez, Ruchika Goel, Sebastian Mayer, Adrienne Phillips, Tsiporah B. Shore, Hsu Jing-Mei, Yen-Michael Sheng Hsu, Ljiljana V. Vasovic, Melissa M. Cushing & Usama Gergis
Pages: 2894-2899
Published online: 14 Jul 2020
AbstractforPoor graft function after T cell-depleted allogeneic hematopoietic stem cell transplant | Full Text | References | PDF (532.2 KB) | EPUB
  • 269 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions
Anna M. Tanasijevic, Anna Revette, Heidi D. Klepin, Amer Zeidan, Danielle Townsley, Courtney D. DiNardo, Marie Sebert, Amy E. DeZern, Richard M. Stone, Emily S. Magnavita, Richard Chen, Mikkael A. Sekeres & Gregory A. Abel
Pages: 2900-2904
Published online: 15 Jul 2020
AbstractforConsensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions | Full Text | References | PDF (533.7 KB) | EPUB | Supplemental
  • 1547 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphoma
Tong Lu, Leonid Gibiansky, Xiaobin Li, Chunze Li, Rong Shi, Priya Agarwal, Jamie Hirata, Dale Miles, Pascal Chanu, Sandhya Girish, Jin Yan Jin & Dan Lu
Pages: 2905-2914
Published online: 24 Jul 2020
AbstractforExposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphoma | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 5261 Views
  • 13 CrossRef citations
  • 0Altmetric
Open Access
Article
Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT
Carmen Martínez, Ariane Boumendil, Joanna Romejko-Jarosinska, Achilles Anagnostopoulos, Edgar Faber, Xavier Poiré, Ibrahim Yakoub-Agha, Saad Akhtar, Gunhan Gurman, Vincenzo Pavone, Kazimierz Halaburda, Aida Botelho Sousa, Hervé Ghesquières, Hervé Finel, Irma Khvedelidze, Silvia Montoto & Anna Sureda
Pages: 2915-2922
Published online: 11 Jul 2020
AbstractforSecond autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT | Full Text | References | PDF (973 KB) | EPUB
  • 214 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Lymphoma survivors have an increased long-term risk of chronic kidney disease
Sanjal H. Desai, Ghassan Al-shbool, Sameer Desale, Judith Veis & Vera Malkovska
Pages: 2923-2930
Published online: 11 Jul 2020
AbstractforLymphoma survivors have an increased long-term risk of chronic kidney disease | Full Text | References | PDF (1,005.9 KB) | EPUB | Supplemental
  • 144 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy
David Straus, Graham Collins, Jan Walewski, Pier Luigi Zinzani, Andrew Grigg, Anna Sureda, Arpad Illes, Tae Min Kim, Sergey Alekseev, Lena Specht, Valeria Buccheri, Anas Younes, Joseph Connors, Andres Forero-Torres, Keenan Fenton, Ashish Gautam, Indra Purevjal, Rachael Liu & Andrea Gallamini
Pages: 2931-2938
Published online: 25 Aug 2020
AbstractforPrimary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy | Full Text | References | PDF (957.1 KB) | EPUB | Supplemental
  • 5656 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Article
Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma
Jacob D. Soumerai, Andy Ni, Anna Alperovich, Connie Batlevi, Kurt S. Bantilan, Thais Fischer, Amanda R. Copeland, Katy Smith, Zhitao Ying, Anas Younes & Andrew D. Zelenetz
Pages: 2939-2946
Published online: 15 Jul 2020
AbstractforTime from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 342 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Low T3 syndrome is a prognostic marker of poor outcomes in secondary hemophagocytic lymphohistiocytosis
Guang-Li Yin, Jia-Yu Huang, Tian Tian, Li-Min Duan, Ji Xu & Hong-Xia Qiu
Pages: 2947-2954
Published online: 09 Jul 2020
AbstractforLow T3 syndrome is a prognostic marker of poor outcomes in secondary hemophagocytic lymphohistiocytosis | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 130 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas
Iris Isufi, Stuart Seropian, Lohith Gowda, Lynn D. Wilson, Kenneth Roberts, Michael Girardi, Sarah Perreault & Francine Foss
Pages: 2955-2961
Published online: 09 Jul 2020
AbstractforOutcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas | Full Text | References | PDF (547.3 KB) | EPUB
  • 524 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Treatment outcomes and prognostic analysis of elderly patients with extranodal natural killer/T-cell lymphoma, nasal type: a retrospective analysis
Liqiang Wei, Jia Cong, Lei Yang, Jin Ye, Xin Li, Na Yao, Jing Yang, Xueying Cui, Yiping Wu, Jing Ding & Jingwen Wang
Pages: 2962-2968
Published online: 20 Jul 2020
AbstractforTreatment outcomes and prognostic analysis of elderly patients with extranodal natural killer/T-cell lymphoma, nasal type: a retrospective analysis | Full Text | References | PDF (987.1 KB) | EPUB
  • 160 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis
Marko Lucijanic, Davor Galusic, Ivan Krecak, Martina Sedinic, Ena Soric, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Tajana Stoos-Veic & Rajko Kusec
Pages: 2969-2974
Published online: 12 Jul 2020
AbstractforC reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis | Full Text | References | PDF (876.1 KB) | EPUB
  • 209 Views
  • 4 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Predictors of short-term survival in Waldenström Macroglobulinemia
Gordon Ruan, Saurabh Zanwar, Jithma P. Abeykoon, Stephen M. Ansell, Morie Gertz, Ronald S. Go, Eli Muchtar, Wilson I. Gonsalves, Jonas Paludo, Gita Thanarajasingam, David J. Inwards, Carrie A. Thompson, Thomas M. Habermann, Yi Lin, Grzegorz S. Nowakowski, Jose C. Villasboas Bisneto, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, David Dingli, Taxiarchis Kourelis, Rahma Warsame, S. Vincent Rajkumar, Shaji Kumar & Prashant Kapoor
Pages: 2975-2979
Published online: 14 Jul 2020
First Page PreviewforPredictors of short-term survival in Waldenström Macroglobulinemia | Full Text | References | PDF (1.1 MB) | EPUB
  • 245 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement
Fateeha Furqan, Grace Watson, Felipe Samaniego, Luis E. Fayad, Rashmi Kanagal-Shamanna , Michael W. Morrison, Philip A. Thompson, Raphael E. Steiner, Linda Chi, Bouthaina Dabaja, Chelsea C. Pinnix, Sattva S. Neelapu, Loretta J. Nastoupil & Paolo Strati
Pages: 2980-2984
Published online: 10 Jul 2020
First Page PreviewforIbrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement | Full Text | References | PDF (1.1 MB) | EPUB
  • 309 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma
Collin K. Chin, Maria A. Rodriguez, Yun Qing, Lei Feng, Felipe Samaniego, Preetesh Jain, Mansoor Noorani, Nathan H. Fowler, Luis E. Fayad, Jason R. Westin, Sattva S. Neelapu, Frederick B. Hagemeister, Christopher R. Flowers & Loretta J. Nastoupil
Pages: 2985-2989
Published online: 06 Jul 2020
First Page PreviewforImpact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma | Full Text | References | PDF (750.5 KB) | EPUB
  • 309 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Anti-apoptotic BCL-2 family proteins confer resistance to calicheamicin-based antibody-drug conjugate therapy of acute leukemia
Colin D. Godwin, Olivia M. Bates, Sae Rin Jean, George S. Laszlo, Eliotte E. Garling, Mary E. Beddoe, Michael H. Cardone & Roland B. Walter
Pages: 2990-2994
Published online: 04 Jul 2020
First Page PreviewforAnti-apoptotic BCL-2 family proteins confer resistance to calicheamicin-based antibody-drug conjugate therapy of acute leukemia | Full Text | References | PDF (993 KB) | EPUB | Supplemental
  • 190 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
The prognostic value of the controlling nutritional status score in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia related changes treated with azacitidine
Aki Sakurai & Tomonori Nakazato
Pages: 2995-2997
Published online: 11 Jul 2020
First Page PreviewforThe prognostic value of the controlling nutritional status score in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia related changes treated with azacitidine | Full Text | References | PDF (366 KB) | EPUB
  • 116 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Evaluation of the impact of timing of pegfilgrastim administration on incidence of febrile neutropenia in elderly patients with B-cell non-Hodgkin lymphomas receiving R-CHOP-21
Matthew M. Lei, Aleksandra N. Watson & Jeremy S. Abramson
Pages: 2998-3001
Published online: 18 Jul 2020
First Page PreviewforEvaluation of the impact of timing of pegfilgrastim administration on incidence of febrile neutropenia in elderly patients with B-cell non-Hodgkin lymphomas receiving R-CHOP-21 | Full Text | References | PDF (575.2 KB) | EPUB
  • 241 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective study
Gessica Marchesini, Gianpaolo Nadali, Davide Facchinelli, Anna Candoni, Chiara Cattaneo, Annarosa Cuccaro, Rosa Fanci, Francesca Farina, Federica Lessi, Andrea Visentin, Francesco Marchesi, Lucia Prezioso, Angelica Spolzino, Maria Chiara Tisi, Fabio Trastulli, Luisa Verga, Michela Dargenio, Alessandro Busca, Livio Pagano & for Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) Group, Italy
Pages: 3002-3005
Published online: 01 Jul 2020
First Page PreviewforInfections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective study | Full Text | References | PDF (858.2 KB) | EPUB
  • 236 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Diffuse large B cell lymphoma: splenectomy as a cure for a spleen-limited disease
Leonid L. Yavorkovsky
Pages: 3006-3009
Published online: 09 Jul 2020
First Page PreviewforDiffuse large B cell lymphoma: splenectomy as a cure for a spleen-limited disease | Full Text | References | PDF (361.7 KB) | EPUB
  • 191 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Acute myeloid leukemia associated with a novel GATA2 mutation: a case report and the importance to identify GATA2 haplodeficiency
Daniela P. Mendes-de-Almeida, Fernando Sellos, Patrícia G. Moura, Filipe V. dos Santos-Bueno, Francianne G. Andrade, Sheila C. Soares-Lima & Maria S. Pombo-de-Oliveira
Pages: 3010-3013
Published online: 27 Jul 2020
First Page PreviewforAcute myeloid leukemia associated with a novel GATA2 mutation: a case report and the importance to identify GATA2 haplodeficiency | Full Text | References | PDF (1.2 MB) | EPUB
  • 136 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center phase I/II experience
Ahmed Sawas, Helen Ma, John Kuruvilla, Jennifer K. Lue, Changchun Deng, Enrica Marchi, Francesca Montanari, Bin Cheng, Kerry J. Savage, Diego Villa, Michael Crump, Joseph M. Connors & Owen A. O’Connor
Pages: 3014-3017
Published online: 28 Jul 2020
First Page PreviewforProlonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center phase I/II experience | Full Text | References | PDF (890.2 KB) | EPUB
  • 272 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant
Ahmad S. Alotaibi, Mustafa Abdulrazzaq, Keyur P. Patel, Farhad Ravandi, Sergej Konoplev, Carlos Bueso-Ramos, C. Cameron Yin, Tariq Muzzafar, Guilin Tang, Andrew Futreal, Nitin Jain, Marina Y. Konopleva & Naveen Pemmaraju
Pages: 3018-3020
Published online: 11 Jul 2020
First Page PreviewforAcute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant | Full Text | References | PDF (423.7 KB) | EPUB
  • 309 Views
  • 6 CrossRef citations
  • 0Altmetric
Letter
Platelet function in patients with chronic myeloid leukemia treated with asciminib
George Nesr, Mike Laffan, Simone Claudiani, Andrew Innes, Jane Apperley & Dragana Milojkovic
Pages: 3021-3023
Published online: 12 Jul 2020
First Page PreviewforPlatelet function in patients with chronic myeloid leukemia treated with asciminib | Full Text | References | PDF (405 KB) | EPUB
  • 333 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Impact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation
Maxwell Brown, Rza Abasov, David Salerno, Tsiporah B. Shore, Usama Gergis, Sebastian Mayer, Adrienne Phillips, Jingmei Hsu, Rosy Priya L. Kodiyanplakkal, Michelle Pasciolla & Koen van Besien
Pages: 3024-3026
Published online: 11 Jul 2020
First Page PreviewforImpact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation | Full Text | References | PDF (335.1 KB) | EPUB
  • 215 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34+ cells is associated with improved survival
Anu Partanen, Antti Turunen, Jaakko Valtola, Marja Pyörälä, Kaija Vasala, Outi Kuittinen, Hanne Kuitunen, Karri Penttilä, Taru Kuittinen, Pentti Mäntymaa, Jukka Pelkonen, Ville Varmavuo & Esa Jantunen
Pages: 3027-3029
Published online: 10 Jul 2020
First Page PreviewforAutologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34+ cells is associated with improved survival | Full Text | References | PDF (491.2 KB) | EPUB
  • 105 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
An atypical systemic form of chronic active EBV infection
Neha Gupta & Adam Bagg
Pages: 3030-3032
Published online: 09 Jul 2020
First Page PreviewforAn atypical systemic form of chronic active EBV infection | Full Text | References | PDF (1.6 MB) | EPUB
  • 108 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles